SpectraBase Spectrum ID |
71Xjncpc0 |
Name |
Pentobarbital-M (OH) 2ME |
Classification |
Pharmaceutical drug metabolite |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
270.157957192 u |
Formula |
C13H22N2O4 |
InChI |
InChI=1S/C13H22N2O4/c1-6-8-12(3,19)13(7-2)9(16)14(4)11(18)15(5)10(13)17/h19H,6-8H2,1-5H3 |
InChIKey |
VKBOUQBYNRDGDA-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
270.329 g/mol |
Nominal Mass |
270 u |
Quality |
899 |
Retention Index |
2056 |
SMILES |
OC(C1(C(N(C(N(C1=O)C)=O)C)=O)CC)(CCC)C |
SPLASH |
splash10-0159-4910000000-511cb10c347ad16002e1 |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-ethyl-5-(2-hydroxypentan-2-yl)-1,3-dimethyl-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_005303 |